This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,516.04 firm fixed-price delivery order is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 4, 2024.
Amerisourcebergen holds two significant indefinite delivery contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively. These IDCs serve as primary vehicles for providing a comprehensive range of pharmaceutical products and medical supplies to support military, veterans', and other federal healthcare programs. The contract awards span various therapeutic areas and medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This particular award was not designated with any set-aside requirements, indicating open competition.
Generated 3/4/25, 11:14 AM